Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Biocompatible Materials in Drug Delivery System in Oncology"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 March 2021) | Viewed by 32175
Special Issue Editors
Interests: cancer therapy; signaling pathways; precision medicine; drug delivery system
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cancers: Cancer Organoids in Basic Science and Translational Medicine
Special Issue Information
Nanomedicine is a growing arena of exciting discoveries with the promise to cure different deadly pathologies. In particular, the drug delivery field has been attracted many attentions from the first discovery of the enhanced permeability effect in tumor in the early 80’s. From passive to active targeting strategies have been applied to better tailored Drug Delivery Systems for each pathology. Although these efforts, only a few are of success such as liposomal doxorubicin and albumin paclitaxel. Among possible explanations of these low rate of success are the type of animal models utilized, no patient stratifications based on the genomic characteristics, a reductionistic approach considering only cancer cells and no consideration of the current standard therapy.
This Special Issue of Pharmaceutics will attempt to cover the recent advancements in the application of Drug Delivery System in Oncology.
Dr. Flavio Rizzolio
Dr. Isabella Caligiuri
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery systems
- personalized therapy
- animal models
- tumor microenvironment